Enthusiasm on pharmaceuticals may create overbought market

Quoted financial analysts, January 1, 2015 – May 5, 2016

New York, May 7, 2016. Quoted financial analysts are strongly optimistic on the pharmaceutical industry but sentiment is so positive, little information on risks is reaching investors, suggesting that excessive enthusiasm could soon price out those not already in the sector, according to new research from Media Tenor International.

“The only risk area analysts are highlighting in the media is the intense competition in the industry which has created some pricing pressures,” says Racheline Maltese, a researcher at Media Tenor. “Even regulatory issues, which are often a risk, were evaluated positively, suggesting strong drug pipelines ahead. However the industry risks being overbought in the face of the intense positivity and little analyst comment on the sector’s past, making it difficult for investors to assess long-term trends.”

Sentiment for the industry was positive in most of the countries analysts focused on, but risks were present in Vietnam due to concerns about a Canadian firm’s investments there.

This research examined all 74,864 analyst statements in eight opinion-leading business media January 1, 2015 – May 5, 2016.

For over 20 years Media Tenor’s mission has been to contribute to objective, diverse and newsworthy media content by bringing together the diverse parties. Media Tenor’s global research projects include analyses of election campaigns, investor relations, public diplomacy, corporate communications and other topics critical to news makers and news audiences.

For more information, please contact Racheline Maltese at This email address is being protected from spambots. You need JavaScript enabled to view it. or
+1 212-935-0210.